Jennifer Kim

Stock Analyst at Cantor Fitzgerald

(1.56)
# 1651
Out of 5,386 analysts
49
Total ratings
Success rate
Average return
14 Stocks
Name Action PT Current % Upside Ratings Updated
BLTE Belite Bio
Reiterates: Overweight
n/a
n/a n/a 5 May 15, 2025
PGEN Precigen
Reiterates: Overweight
n/a
n/a n/a 4 May 15, 2025
INSM Insmed
Reiterates: Overweight
n/a
n/a n/a 8 Feb 20, 2025
FBIO Fortress Biotech
Reiterates: Overweight
n/a
n/a n/a 4 Jun 20, 2024
EYPT EyePoint Pharmaceuti...
Reiterates: Overweight
n/a
n/a n/a 6 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 4 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
14
n/a n/a 2 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
1.01 98.02% 2 Aug 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
19 14
n/a n/a 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
33
3.22 924.84% 2 Jul 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 5
2.04 120.59% 2 May 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8
n/a n/a 2 Mar 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
220 100
2.09 4684.69% 2 May 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
84 56
n/a n/a 2 Mar 17, 2022